West Pharmaceutical Services Inc

مادة اعلانية

Latest Update: 25 July 2025 23:59 Abu Dhabi Time.

Market Status: Closed

WST

West Pharmaceutical Services Inc

263.42

USD

-15.680

-5.62%

Open

279.10

Prev Close

279.10

PX_VOLUME

MARKET CAP (M)

DAY RANGE

261.00 - 279.63

52 WEEKS

187.43 - 352.33

Stock Statistics

Yearly Change

-4.92%

Listed Shares (Million)

75.30

Earnings Multiple

39.52

Average 30-day trading volume

734,328.22

Price-to-book ratio

6.47

Earnings Per Share

6.75

Previous Dividend Distribution

0.84

Dividend Yield

0.32%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		766.50	698.00	748.80	746.90	702.10	695.40	732.00	747.40
Gross Profit		273.90	231.90	273.60	264.70	230.00	230.20	278.20	288.30
Operating Income		157.80	126.30	167.90	163.90	128.50	124.60	167.80	185.40
Net Income		126.80	86.40	128.10	132.10	106.80	111.00	133.70	157.60
Profit Margin		16.54	12.38	17.11	17.69	15.21	15.96	18.27	21.09

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		2,893.20	2,949.80	2,886.90	2,831.60	2,146.90
Gross Profit		998.50	1,129.20	1,136.20	1,177.70	767.80
Operating Income		589.50	709.40	754.90	757.20	417.70
Net Income		478.00	575.70	559.50	640.30	328.80
Profit Margin		16.52	19.52	19.38	22.61	15.32

Balance Sheet

	Period Ending:	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		3,952.80	3,618.20	3,643.40	3,675.10	3,489.40	3,602.30	3,829.50	3,754.70
Total Liabilities		1,023.70	935.10	961.10	923.00	912.60	921.70	948.50	886.50
Total Equity		2,929.10	2,683.10	2,682.30	2,752.10	2,576.80	2,680.60	2,881.00	2,868.20

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		3,643.40	3,829.50	3,616.80	3,313.80	2,793.80
Total Liabilities		961.10	948.50	931.90	978.40	939.30
Total Equity		2,682.30	2,881.00	2,684.90	2,335.40	1,854.50

Cash Flows Statements

	Period Ending:	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		177.10	129.40	190.10	180.10	165.00	118.20	239.10	230.10
Cash From Investing Activities		-75.20	-71.30	-104.80	-82.10	-101.20	-90.60	-108.80	-95.70
Cash From Financing Activities		-14.90	-147.00	-68.90	-64.40	-218.30	-271.00	-189.50	-22.30
Net Change in Cash		105.50	-80.40	-6.30	44.70	-155.60	-252.10	-44.70	102.30

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		653.40	776.50	724.00	584.00	472.50
Cash From Investing Activities		-378.70	-368.70	-288.20	-253.10	-179.50
Cash From Financing Activities		-622.60	-459.60	-293.60	-168.10	-137.10
Net Change in Cash		-369.30	-40.40	131.70	147.10	176.40

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

WST

West Pharmaceutical Services Inc

ويست فارماسوتيكال سيرفيسز إنك